ECMO-SL-CoV-2: Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Completed
CT.gov ID
NCT04446286
Collaborator
(none)
50
Enrollment
1
Location
2
Actual Duration (Months)
24.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Describes the cohort of patients receiving ECMO-VV or ECMO-VA in the management of severe ARDS refractory to SARS-CoV-2 in the Strasbourg and Louvain centres

Condition or DiseaseIntervention/TreatmentPhase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    50 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Other
    Official Title:
    Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19
    Actual Study Start Date :
    Jun 18, 2020
    Actual Primary Completion Date :
    Aug 18, 2020
    Actual Study Completion Date :
    Aug 18, 2020

    Outcome Measures

    Primary Outcome Measures

    1. Retrospective description of effect of the ECMO-VV or ECMO-VA in the management of severe ARDS refractory in patients of the Strasbourg and Louvain centres with covid-19 [files analysed retrospectily from March 1st, 2020 to August 1st, 2020 will be examined]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Patient over the age of 18;

    • Diagnostic COVID-19 by RT-PCR;

    • Hospitalisation in resuscitation for the management of complications related to COVID-19

    • Implanted ECMO-VV or VA during hospitalisation;

    • Patient agreeing to participate in the study

    Exclusion Criteria:
    • Sujet who has expressed opposition to participating in the study.

    • Sujet under guardianship or trusteeship

    • Sujet under safeguard of justice

    Contacts and Locations

    Locations

    SiteCityStateCountryPostal Code
    1Service de Chirurgie Thoracique Nouvel Hôpital Civil Hôpitaux Universitaires de StrasbourgStrasbourgFrance67091

    Sponsors and Collaborators

    • University Hospital, Strasbourg, France

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Strasbourg, France
    ClinicalTrials.gov Identifier:
    NCT04446286
    Other Study ID Numbers:
    • 7904
    First Posted:
    Jun 24, 2020
    Last Update Posted:
    Oct 8, 2021
    Last Verified:
    Jun 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Strasbourg, France
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 8, 2021